Crossref
Interleukin 5 as a therapeutic target in severe asthma
Alergologia Polska - Polish Journal of Allergology · 2026 · 13 (1) · 21-27
DOI: 10.5114/pja.2026.159591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alergologia Polska - Polish Journal of Allergology, 2026. Verfasst von Hubert Bajer und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bajer, H., & Pawliczak, R. (2026). Interleukin 5 as a therapeutic target in severe asthma. Alergologia Polska - Polish Journal of Allergology, 13(1), 21-27. https://doi.org/10.5114/pja.2026.159591
Vancouver
Bajer H, Pawliczak R. Interleukin 5 as a therapeutic target in severe asthma. Alergologia Polska - Polish Journal of Allergology. 2026;13(1):21-27. doi:10.5114/pja.2026.159591
BibTeX
@article{Bajer2026,
author = {Bajer, Hubert and Pawliczak, Rafał},
title = {Interleukin 5 as a therapeutic target in severe asthma},
journal = {Alergologia Polska - Polish Journal of Allergology},
year = {2026},
volume = {13},
number = {1},
pages = {21--27},
doi = {10.5114/pja.2026.159591}
}
EUVIMED